Bomback, Andrew S.

Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review

Bomback, A. S., Kshirsagar, A. V., Amamoo, M. A., & Klemmer, P. J. (2008) · American Journal of Kidney Diseases

Hormonal Regulation and HypertensionChronic Kidney Disease and Diabetes

Cited by 261

Rationale and design of the Kidney Precision Medicine Project

de Boer, I. H., Alpers, C. E., Azeloglu, E. U., Balis, U. G. J., Barasch, J. M., Barisoni, L., Blank, K. N., Bomback, A. S., Brown, K., Dagher, P. C., et al. (2021) · Kidney International

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 187

Low-dose spironolactone, added to long-term ACE inhibitor therapy, reduces blood pressure and urinary albumin excretion in obese patients with hypertensive target organ damage

Bomback, A. S., Muskala, P., Bald, E., Chwatko, G., & Nowicki, M. (2009) · Clinical Nephrology

Hormonal Regulation and HypertensionBlood Pressure and Hypertension Studies

Cited by 34

A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy

Bomback, A. S., Song, H., D'Agati, V. D., Cohen, S. D., Neal, A., Appel, G. B., & Rovin, B. H. (2010) · Nephrology Dialysis Transplantation

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 25

Individualised treatment effects of corticosteroids in IgA nephropathy

Hölscher, D. L., Schmitz, N. E. J., Niggemeier, L., Pilva, P., Strauch, M., Tesar, V., Barratt, J., Roberts, I. S. D., Coppo, R., Barisoni, L., et al. (2026) · eBioMedicine

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 2

Genome-wide studies define genetic mechanisms of IgA vasculitis

Liu, L., Zhu, L., Monteiro-Martins, S., Griffin, A., Vlahos, L. J., Fujita, M., Taylor, A. D., Berrouet, C., Zanoni, F., Marasa, M., et al. (2026) · Nature Communications

Vasculitis and related conditionsRenal Diseases and Glomerulopathies

Cited by 1